Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

BioSpark AI Technologies

3 abstracts

Abstract
Utilizing large language models (LLMs) to pre-label candidate concepts from in conceptual development landscape reviews in oncology.
Org: BioSpark AI Technologies, BioSpark AI Technologies Inc.,
Abstract
Evaluating progression-free survival of EGFR exon 20ins in patients with advanced non-small lung cancer receiving EGFR inhibitors: A real-world data study.
Org: BioSpark AI Technologies,
Abstract
Is aggregate use of published case reports as a viable option for augmenting pharmacovigilance? An applied example of pembrolizumab-related adverse events in patients with non-small cell lung cancer receiving first-line treatment.
Org: McMaster University and Juravinski Cancer Centre, BioSpark AI Technologies, University of Massachusetts Chan Medical School,